Navigation Links
Photonic Products Group, Inc. Reports Record Financial Results for FY 2007
Date:3/31/2008

l performance, or of the Company's liquidity. The reader is referred to the Supplemental Financial Data set forth below for a reconciliation of net income to EBITDA.

At December 31,

Reconciliation of EBITDA to

Net Income 2007 2006 2005

Net income (loss), as reported $1,880,000 $ 772,000 $ (11,000)

Non-cash, stock-based

compensation 34,000 118,000 21,000

Non-GAAP based net income 1,914,000 890,000 10,000

Income tax provision 250,000 21,000 -

Interest expense, net 261,000 402,000 505,000

Depreciation and Amortization 1,120,000 1,099,000 970,000

EBITDA $3,545,000 $2,412,000 $1,485,000

Photonic Products Group, Inc. develops, manufactures, and markets products and services for use in diverse Photonics industry sectors via its expanding portfolio of distinctly branded businesses. INRAD specializes in crystal-based optical components and devices, laser accessories and instruments. Laser Optics specializes in precision custom optical components, assemblies, and optical coatings. MRC Optics' business specializes in precision diamond turned optics, metal optics, and opto-mechanical and electro-optical assemblies. PPGI's customers include leading corporations in the Defense and Aerospace, Laser Systems, and Process Control and Metrology sectors of the Photonics Industry, as well as the U.S. Government. Its products are also used by researchers at National Laboratories and Universities world-wide.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this press release that are not purely historical are forward looking statements within the meaning of Section 27A of the
'/>"/>

SOURCE Photonic Products Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Professor Straufs research is Nature Photonics’ cover article
2. 3-D photonic crystals will revolutionize telecommunications
3. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
4. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
5. Live Demos With Hydrogen, New Fuel Cell Products
6. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
7. Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
8. iCAD to Feature New Products and Capabilities at European Congress of Radiology
9. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
10. China Biologic Products Commences Trading on OTC Bulletin Board
11. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015   BioClinica ® , Inc., a ... that David Peters , an accomplished senior finance ... and Chief Financial Officer (CFO) and will be joining ... more than 25 years of financial and accounting experience ... and deep knowledge in all areas of finance, accounting ...
(Date:6/2/2015)... 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO ) ... leading provider of cord blood collection, laboratory testing, ... announced that the Special Committee of the Company,s board of ... ( China ) Limited as its independent financial ... its United States legal counsel and ...
(Date:6/2/2015)... 2015 MGB Biopharma at ... problem  MGB Biopharma, a biopharmaceutical company ... address the major global problem of antibiotic resistance ... intravenous (IV) formulation of MGB-BP-3, designed for the treatment ... The intravenous formulation of MGB-BP-3 is currently ...
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
Breaking Biology Technology:BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3
... ... , ... , , ... ...
... ... ... , ... , , , ...
... ... ... , ... ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2009 2Amsterdam Molecular Therapeutics Reports Full Year Results 2009 3Amsterdam Molecular Therapeutics Reports Full Year Results 2009 4Amsterdam Molecular Therapeutics Reports Full Year Results 2009 5Amsterdam Molecular Therapeutics Reports Full Year Results 2009 6Amsterdam Molecular Therapeutics Reports Full Year Results 2009 7Amsterdam Molecular Therapeutics Reports Full Year Results 2009 8Amsterdam Molecular Therapeutics Reports Full Year Results 2009 9Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial 2Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial 3Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial 4Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial 5Predicted Second Wave of Biotech Growth and Development Begins 2Predicted Second Wave of Biotech Growth and Development Begins 3Predicted Second Wave of Biotech Growth and Development Begins 4Predicted Second Wave of Biotech Growth and Development Begins 5Predicted Second Wave of Biotech Growth and Development Begins 6Predicted Second Wave of Biotech Growth and Development Begins 7Predicted Second Wave of Biotech Growth and Development Begins 8Predicted Second Wave of Biotech Growth and Development Begins 9Predicted Second Wave of Biotech Growth and Development Begins 10Predicted Second Wave of Biotech Growth and Development Begins 11
(Date:5/14/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) ... Market in Smart Mobile Devices " report to ... was a watershed year for fingerprint sensors in smartphones ... Apple gave fingerprint sensors a raison d,etre in the ... are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... Brain cells in a mouse model of Alzheimer's,disease ... the disorder's characteristic brain plaques are removed.,Researchers at ... mice with an antibody for a key component ... areas of the brain where,antibodies cleared plaques, many ...
... with aiding efforts to study addicted,smokers, a new ... brain that have,been implicated in nicotine addiction ... such as Alzheimer’s,disease and schizophrenia.,Developed by UC Irvine ... ?Nifrolidine ?is a selective binding agent,that identifies specific ...
... cells have been contaminated with a non-human molecule ... to research by investigators at the University of ... Salk Institute in La Jolla,California.,In a study published ... the researchers found that human embryonic stem cells,including ...
Cached Biology News:Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 2Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 3Drug That 'Tags' Decision-making Areas Of The Brain May Aid 2Current human embryonic stem cell lines contaminated UCSD/Salk team finds 2Current human embryonic stem cell lines contaminated UCSD/Salk team finds 3Current human embryonic stem cell lines contaminated UCSD/Salk team finds 4
... Molecular Probes intensely fluorescent and highly ... for use in a variety of ... a strong signal. Unfortunately, protein- and ... that may cause them to bind ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... Description: Proteinase K is a highly active and ... applications purified from the fungus T. album. It ... of N-substituted hydrophobic aliphatic and aromatic amino acids ... protease. Proteinase K is useful in purifying high ...
...
Biology Products: